MIM
ZBH icon

Meixler Investment Management’s Zimmer Biomet ZBH Stock Holding History

Meixler Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,132
Closed -$239K – 99
2023
Q3 		$239K Sell
2,132
-752
-26% -$95.5K 0.21% 68
2023
Q2 		$420K Sell
2,884
-153
-5% -$20.8K 0.39% 46
2023
Q1 		$392K Sell
3,037
-155
-5% -$19.5K 0.38% 49
2022
Q4 		$407K Sell
3,192
-47
-1% -$5.45K 0.41% 48
2022
Q3 		$339K Sell
3,239
-47
-1% -$5.16K 0.4% 49
2022
Q2 		$345K Buy
3,286
+52
+2% +$6.17K 0.4% 49
2022
Q1 		$414K Buy
+3,234
New +$390K 0.4% 49

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meixler Investment Management's ZBH Position: Q4 2023 in Review

Meixler Investment Management sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 2,132 shares — an estimated $239K sold.

Meixler Investment Management first reported a position in ZBH in Q1 2022 and held it in 7 quarters. The position peaked at $420K in Q2 2023. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

  • Meixler Investment Management reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
  • Meixler Investment Management sold 2,132 Zimmer Biomet shares in Q4 2023, an estimated $239K.
  • Meixler Investment Management first reported a position in Zimmer Biomet in Q1 2022 and held it in 7 quarters.
  • Meixler Investment Management's Zimmer Biomet position peaked at $420K in Q2 2023.
  • 1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on Meixler Investment Management's 13F filing for Q4 2023, filed 2 Feb 2024.